SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience is a global contract research organization (CRO) specializing in oncology drug discovery and development, today announced it has joined Critical Path Institute’s (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC), a collaborative initiative dedicated to advancing the validation, qualification and regulatory adoption of innovative human-relevant research methods. Crown Bioscience joins a growing community of technology developers, pharm
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
